Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2278-2282

  Hickman Davis, Judy M ^a   Michalek, Suzanne M ^a   Gibbs Erwin, Julie ^a   Lindsey, J Russell ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAM NEGATIVE INFECTION; HOST RESISTANCE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030955848     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2278-2282.1997     Document Type: Article

References (44)

1. Berg, J. T., S. T. Lee, T. Thepen, C. Lee, and M. Tsan. 1993. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphate. J. Appl. Physiol. 74:2812-2819.
2. Bette. M., M. K.-H. Schafer, N. van Rooijen, E. Weihe, and B. Fleisher. 1993. Distribution and kinetics of super-antigen induced cytokine gene expression in mouse spleen. J. Exp. Med. 178:1531-1540.
3. Buiting, A. M. J., and N. van Rooijen. 1994. Liposome mediated depletion of macrophages: an approach for fundamental studies. J. Drug Target 2:357- 362.
4. Cartner, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138-4142.
5. Cassell, G. H., W. A. Clyde, Jr., and J. K. Davis. 1985. Mycoplasma respiratory infections, p. 65-106. In S. Razin (ed.), The mycoplasmas. Academic Press, New York, N.Y.
6. Cassell, G. H., J. R. Lindsey, R. G. Overcash, and H. J. Baker. 1973. Murine mycoplasma respiratory disease. Ann. N. Y. Acad. Sci. 225:395-412.
7. Claasen, E., and N. van Rooijen. 1986. Preparation and characteristics of dichloromethylene diphosphate-containing liposomes. J. Microencapsulalion 3:109-114.
8. Clyde, W. A. 1983. Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J. Biol. Mcd. 56:523-527.
9. Couch, R. B. 1990. Mycoplasma diseases, p. 1445-1458. In Gerald L. Mandell, R. Gorden Douglas, and John E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, N.Y.
10. Dave, J., and H. M. Patel. 1986. Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes. Biochim. Biophys. Acta 888:184-190.
11. Davidson, M. K., J. R. Lindsey, R. F. Parker, J. G. Tully, and G. H. Cassell. 1988. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect. Immun. 56:2156-2162.
12. Davis, J. K., M. K. Davidson, and T. R. Schoeb. 1991. Murine respiratory mycoplasmosis: a model to study effects of oxidants. Research report 47. Health Effects Institute, Cambridge, Mass.
13. 2 is associated with damaged alveolar macrophages. Am. Rev. Respir. Dis. 145:406-411.
14. Davis, J. K., K. M. Delozier, D. K. Asa, F. C. Minion, and G. H. Cassell. 1980. Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect. Immun. 29:590-599.
15. Davis, J. K., R. F. Parker, H. White, D. Dziedzic, G. Taylor, M. K. Davidson, N. R. Cox, and G. H. Cassell. 1985. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6N and C3H/HeN mice. Infect. Immun. 50:647-654.
16. Evengard, B., K. Sandstedt, G. Bolske, R. Feinstein, I. Riesenfelt-Orn, and C. I. E. Smith. 1995. Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis. Clin. Exp. Immunol. 98:388-394.
17. Faulkner, C. B., J. W. Simecka, M. K. Davidson, J. K. Davis, T. R. Schoeb, J. R. Lindsey, and M. P. Everson. 1995. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect. Immun. 63:4084-4090.
18. Fleisch, H. 1989. Biphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Recent Results Cancer Res. 166:1-28.
19. Foy, H. M. 1993. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis. 17:537-546.
20. Gnarpe, J., A. Lundback, and B. Sundelof. 1992. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand. J. Infect. Dis. 24:161- 164.
21. Hatch, G. E., M. K. Selgrade, and A. G. Steade. 1986. Nitrogen dioxide exposure and lung antioxidants in ascorbic acid-deficient guinea pigs. Toxicol. Appl. Pharmacol. 82:351-359.
22. Higuchi, S., M. Suga, A. M. Dannenburg, Jr., and B. H. Schofleld. 1979. Histochemical demonstration of enzyme activities in plastic and paraffin embedded tissue sections. Stain Technol. 54:5-12.
23. Krause, D. C., and D. Taylor-Robinson. 1992. Mycoplasmas which infect humans. p. 417-444. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
24. Lai, W. C., M. Bennett, S. P. Pakes, V. Kumar, D. Steutermann, I. Owusu, and A. Mikheal. 1940. Resistance to Mycoplasma pulmonis is mediated by activated natural killer cells. J. Infect. Dis. 161:1269-1275.
25. Lai, W. C., S. P. Pakes, Y. S. Lu, and C. F. Brayton. 1987. Mycoplasma pulmonis infection augments natural killer cell activity. Lab. Anim. Sci. 37:299-303.
26. Lo, S-C. 1992. Mycoplasmas and AIDS, p. 525-545. In J. Maniloff. R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
27. Miturka, B. M., and H. M. Rawnsley. 1977. Clinical biochemical and hematological reference values in normal experimental animals. MASSON Publishing USA, Inc., New York, N.Y.
28. Monkkonen, J., and T. D. Heath. 1993. The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron. Calcif. Tissue Int. 53:139-146.
29. Parker, R. F., J. K. Davis, D. K. Blalock, R. B. Thorp, J. W. Simecka, and G. H. Cassell. 1987. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect. Immun. 55:2631-2635.
30. Parker, R. F., J. K. Davis, G. H. Cassell, H. White, D. Dziedzic, D. K. Blalock, R. B. Thorp, and J. W. Simecka. 1989. Short term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis. Am. Rev. Respir. Dis. 140:502-512.
31. Pelorgeas, S., J.-B. Martin, and M. Satre. 1992. Cytotoxicity of dichloromethane diphosphonate in the amoebae of the slime mold Dictyostelium discoideum. Biochem. Pharmacol. 44:2157-2163.
32. Proffitt, R. T., L. E. Williams, C. A. Prescant, G. W. Tin, J. A. Uliana, R. C. Gamble, und J. D. Baldeschwieler. 1983. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science 220:502-505.
33. Qian, Q., M. A. Jutila, N. van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
34. Schultz, D. 1994. Lung disease data 1994, p. 39-40. American Lung Association, New York, N.Y.
35. Sherwin, R. P., and D. A. Carlson. 1973. Protein content of lung lavage fluid of guinea pigs exposed to 0.4 ppm nitrogen dioxide. Arch. Environ. Health 27:90-93.
36. Siegel, J. 1992. Statistix. Analytical Software, St. Paul, Minn.
37. Simecka, J. W., J. K. Davis, M. K. Davidson, S. E. Ross, C. T. K.-H. Stadtlander, and G. H. Cassell. 1992. Mycoplasma diseases of animals, p. 391-415. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
38. Thepen, T., C. McMenamin, J. Oliver, G. Kraal, and P. G. Holt. 1991. Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur. J. Immunol. 21:2845-2850.
39. Thepen, T., N. van Rooijen, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170:499-509.
40. van Rooijen, N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 124:1-6.
41. van Rooijen, N., M. van de Ende, and C. D. Dijkstra. 1990. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 260:215-222.
42. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome mediated depletion. J. Leukocyte Biol. 45:97-104.
43. van Rooijen, N., and R. van Nieuwmegen. 1984. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 238:355-358.
44. van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174:83-93.